Capital Goods Healthcare Sector

Regulus Therapeutics

Market Cap: US$546.3m

A clinical-stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States.

Xencor

Market Cap: US$538.8m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune diseases, and cancer.

Butterfly Network

Market Cap: US$536.6m

Develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally.

Eton Pharmaceuticals

Market Cap: US$531.3m

A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.

InnovAge Holding

Market Cap: US$530.9m

Manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities.

LifeMD

Market Cap: US$524.0m

Operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States.

Enhabit

Market Cap: US$517.5m

Provides home health and hospice services in the United States.

OrthoPediatrics

Market Cap: US$515.9m

A medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally.

Stoke Therapeutics

Market Cap: US$511.0m

An early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression.

Bicara Therapeutics

Market Cap: US$505.6m

A clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors.

Axogen

Market Cap: US$504.2m

Develops and commercializes technologies for peripheral nerve regeneration and repair worldwide.

Relay Therapeutics

Market Cap: US$498.9m

Operates as a clinical-stage precision medicines company.

Semler Scientific

Market Cap: US$494.2m

Provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States.

Owens & Minor

Market Cap: US$494.2m

Operates as a healthcare solutions company worldwide.

Tyra Biosciences

Market Cap: US$494.0m

A clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States.

Upstream Bio

Market Cap: US$492.8m

A clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders.

Auna

Market Cap: US$491.9m

A healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia.

Community Health Systems

Market Cap: US$490.9m

Owns, leases, and operates general acute care hospitals in the United States.

Kura Oncology

Market Cap: US$488.3m

A clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer.

REGENXBIO

Market Cap: US$487.1m

A clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States.

Virtus Health

Market Cap: AU$705.2m

Virtus Health Limited provides various healthcare services in Australia, Denmark, the United Kingdom, Ireland, and Singapore.

Allergy Therapeutics

Market Cap: UK£357.5m

A commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders.

Zenas BioPharma

Market Cap: US$478.2m

A clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies.

Opthea

Market Cap: AU$738.8m

A clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States.

Arvinas

Market Cap: US$475.2m

A clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.

Amylyx Pharmaceuticals

Market Cap: US$473.3m

A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.

Zevra Therapeutics

Market Cap: US$473.0m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Talkspace

Market Cap: US$471.8m

Operates as a virtual behavioral healthcare company that connects patients with licensed mental health providers in the United States.

SBC Medical Group Holdings

Market Cap: US$471.4m

Provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore.

Capricor Therapeutics

Market Cap: US$468.5m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

Botanix Pharmaceuticals

Market Cap: AU$725.5m

Engages in the research and development of dermatology and antimicrobial products in Australia and the United States.

Theravance Biopharma

Market Cap: US$465.0m

A biopharmaceutical company, develops and commercializes of medicines in the United States.

Castle Biosciences

Market Cap: US$464.8m

A molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), uveal melanoma, and mental health conditions.

Altimmune

Market Cap: US$463.1m

A clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases.

Cullinan Therapeutics

Market Cap: US$460.9m

A clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States.

Oxford Biomedica

Market Cap: UK£339.2m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.